(688050)"Eyebright Medical Technology (Beijing) Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 688050 · · 12 pages · Chinese
Summary by 6ix AI
The report includes significant changes in financial indicators, primarily due to the acquisition of another company and increased sales of contact lenses. The financial statements included in the report are unaudited, and the company assures the accuracy and completeness of the information presented.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Eyebright Medical Technology (Beijing) Co., Ltd. on 6ix
Earlier from Eyebright Medical Technology (Beijing)
- Announcement on Signing Quadripartite Supervision Agreement for Deposit of Raised Funds in Special Account
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Vesting Results in the 4th Vesting Period of Reserved Grant Portion under the 2021 Restricted Stock Incentive Plan and Stock Listing
- Announcement on Resignation and By-election of Employee Director
Follow Eyebright Medical Technology (Beijing) into a list and get an email when it puts out news.
Follow Eyebright Medical Technology (Beijing)